Bristol-Myers Squibb (BMY) Earnings Date, Estimates & Call Transcripts $50.95 +0.94 (+1.88%) (As of 09/24/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateOct. 31Before Market OpensConfirmedActual EPS (Jul. 26) $2.07 Beat By $0.43 Consensus EPS (Jul. 26) $1.64 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K Filing Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBMY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BMY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election. Click here now to grab your seat now. Bristol-Myers Squibb Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244$1.51$2.07$1.72 Q2 20244$1.63$2.00$1.75 Q3 20244$1.51$1.91$1.68 Q4 20244$1.51$1.84$1.65 FY 202416$6.16$7.82$6.80 Q1 20252$1.71$1.83$1.77 Q2 20252$1.79$1.90$1.85 Q3 20252$1.66$1.88$1.77 Q4 20252$1.78$1.87$1.83 FY 20258$6.94$7.48$7.21 Q1 20261$1.47$1.47$1.47 Q2 20261$1.69$1.69$1.69 BMY Earnings Date and InformationBristol-Myers Squibb last announced its quarterly earnings results on July 26th, 2024. The biopharmaceutical company reported $2.07 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.43. The firm earned $12.20 billion during the quarter, compared to analysts' expectations of $11.54 billion. Its revenue was up 8.7% on a year-over-year basis. Bristol-Myers Squibb has generated ($3.10) earnings per share over the last year (($3.10) diluted earnings per share). Earnings for Bristol-Myers Squibb are expected to grow by 820.78% in the coming year, from $0.77 to $7.09 per share. Bristol-Myers Squibb has confirmed that its next quarterly earnings report will be published on Thursday, October 31st, 2024. Bristol-Myers Squibb will be holding an earnings conference call on Thursday, October 31st at 8:00 AM Eastern. Interested parties can register for or listen to the call.. Read More Bristol-Myers Squibb Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/31/2024(Confirmed)------- 7/26/2024Q2 2024$1.64$2.07+$0.43$3.31$11.54 billion$12.20 billion 4/25/2024Q1 2024($4.53)($4.40)+$0.13$9.69$11.45 billion$11.87 billion 2/2/2024Q4 2023$1.55$1.70+$0.15$2.53$11.19 billion$11.48 billion 10/26/2023Q3 2023$1.76$2.00+$0.24$3.07$10.96 billion$10.97 billion 7/27/2023Q2 2023$1.99$1.75($0.24)$2.51$11.81 billion$11.23 billion 4/27/2023Q1 2023$1.98$2.05+$0.07$3.03$11.50 billion$11.34 billion The most serious warning of my career (Ad)With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election. Click here now to grab your seat now.2/2/2023Q4 2022$1.71$1.82+$0.11$2.69$11.20 billion$11.41 billion 10/25/2022Q3 2022$1.83$1.99+$0.16$3.23$11.18 billion$11.22 billion 7/27/2022Q2 2022$1.79$1.93+$0.14$3.20$11.50 billion$11.89 billion 4/29/2022Q1 2022$1.92$1.96+$0.04$3.33$11.34 billion$11.65 billion 2/4/2022Q4 2021$1.83$1.83-$2.59$12.00 billion$11.96 billion 10/26/2021Q3 2021$1.92$2.00+$0.08$3.31$11.52 billion$11.62 billion 7/27/2021Q2 2021$1.89$1.93+$0.04$3.39$11.24 billion$11.70 billion 4/28/2021Q1 2021$1.82$1.74($0.08)$2.59$11.19 billion$11.07 billion 2/3/2021Q4 2020$1.42$1.46+$0.04$7.37$10.74 billion$11.07 billion 11/10/2020Q3 2020$1.49$1.63+$0.14$2.44$10.33 billion$10.54 billion 8/6/2020Q2 2020$1.48$1.63+$0.15$3.30$10.04 billion$10.13 billion 5/7/2020Q1 2020$1.49$1.72+$0.23$3.78$10.04 billion$10.78 billion 2/6/2020Q4 2019$0.88$1.22+$0.34$2.99$6.20 billion$7.95 billion 10/31/2019Q3 2019$2.70$2.99+$0.29$3.18$4.39 billion$4.52 billion 10/31/2019Q3 2019$1.06$1.17+$0.11$1.51$5.89 billion$6.01 billion Bristol-Myers Squibb Earnings - Frequently Asked Questions When is Bristol-Myers Squibb's earnings date? Bristol-Myers Squibb has confirmed that its next quarterly earnings data will be published on Thursday, October 31st, 2024. Learn more on BMY's earnings history. What guidance has Bristol-Myers Squibb issued on next quarter's earnings? Bristol-Myers Squibb updated its FY 2024 earnings guidance on Friday, July, 26th. The company provided earnings per share (EPS) guidance of 0.600-0.900 for the period, compared to the consensus earnings per share estimate of 0.510. The company issued revenue guidance of -. Did Bristol-Myers Squibb beat their earnings estimates last quarter? In the previous quarter, Bristol-Myers Squibb (NYSE:BMY) reported $2.07 earnings per share (EPS) to beat the analysts' consensus estimate of $1.64 by $0.43. Learn more on analysts' earnings estimate vs. BMY's actual earnings. How can I listen to Bristol-Myers Squibb's earnings conference call? The conference call for Bristol-Myers Squibb's latest earnings report can be listened to online. Listen to Conference Call How can I read Bristol-Myers Squibb's conference call transcript? The conference call transcript for Bristol-Myers Squibb's latest earnings report can be read online. Read Transcript How can I view Bristol-Myers Squibb's earnings report? Bristol-Myers Squibb's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Bristol-Myers Squibb generate each year? Bristol-Myers Squibb (NYSE:BMY) has a recorded annual revenue of $46.51 billion. How much profit does Bristol-Myers Squibb generate each year? Bristol-Myers Squibb (NYSE:BMY) has a recorded net income of $8.03 billion. BMY has generated -$3.10 earnings per share over the last four quarters. What is Bristol-Myers Squibb's price-to-earnings ratio? Bristol-Myers Squibb (NYSE:BMY) has a forward price-to-earnings ratio of 66.17. The price/earnings-to-growth ratio is 12.59. What is Bristol-Myers Squibb's EPS forecast for next year? Bristol-Myers Squibb's earnings are expected to grow from $0.77 per share to $7.09 per share in the next year, which is a 820.78% increase. More Earnings Resources from MarketBeat Related Companies: JNJ Earnings Date ABBV Earnings Date MRK Earnings Date PFE Earnings Date ZTS Earnings Date RPRX Earnings Date JAZZ Earnings Date CORT Earnings Date PRGO Earnings Date SUPN Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NYSE:BMY) was last updated on 9/25/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
